Dr. Brian William Rothlisberger, MD

Dr. Rothlisberger practices at Gabriel Jacob MD, a Medical Corporation in Roseville, California.

Dr. Rothlisberger's NPI, 1609893338, was assigned on July 17, 2006. Dr. Rothlisberger graduated from VCU School of Medicine in 2001. Dr. Rothlisberger holds California license A92549.

Dr. Rothlisberger's primary practice is Gabriel Jacob MD, a Medical Corporation, at 2510 Douglas Blvd, Roseville, CA 95661 in Placer County. The practice phone is (916) 423-2134.

Dr. Rothlisberger's primary practice is Gabriel Jacob MD, a Medical Corporation in Roseville, California. Dmand AI also links Dr. Rothlisberger to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rothlisberger practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rothlisberger's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rothlisberger is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Rothlisberger's licenses on file in 3 states: California, Colorado and Virginia.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Rothlisberger treats.

CMS data shows 2,393 Medicare services from Dr. Rothlisberger across 9 procedure codes in 2024, for 1,022 Medicare patients. Medicare paid $156,320 for them. Every service was in an office.

CMS counts 1,022 Medicare patients who saw Dr. Rothlisberger in 2024. The largest group is 75 to 84, with 426 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rothlisberger's median patient age at 74, with 60% women.

In 2024, Dr. Rothlisberger wrote 2,189 Medicare Part D claims for 653 patients. 53% of them were for generic drugs. CMS names the drug for 2,085 of them, across 22 drugs with 11 or more claims each, at $313,118 in total drug cost. In 2023, CMS named 1,871 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Rothlisberger for performance year 2024, reported individually. Dr. Rothlisberger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 65 procedures of cataract surgery by Dr. Rothlisberger, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Rothlisberger.

CMS Open Payments shows 114 general payments to Dr. Rothlisberger from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Novartis Pharmaceuticals Corporation paid the most, $412.

Dmand AI lists 2 awards for Dr. Rothlisberger, most recently CMS Stage 1 EHR in 2013.

Dr. Rothlisberger graduated from VCU School of Medicine in 2001. Dr. Rothlisberger is a member of AAO.

Dr. Rothlisberger is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.